“disagree, it's PR, not science. CYDY should hav
Post# of 148278
(Total Views: 622)
Posted On: 04/26/2021 2:14:58 PM
“disagree, it's PR, not science. CYDY should have put out an immediate PR that said Fr. Pres. Estrada has immediate recovery because of Leronlimab, no tip toe, mess around.
CYDY will never release a PR making that claim because they cannot prove it definitively due to the other medications he was on. Yes, I agree, it’s likely his quick recovery and removal of the vent was due to leronlimab.
“PR is playing to the public, not to scientists.”
The PR is also playing to the SEC and the FDA. Stating that a drug still in trials is the reason for Estrada’s improvement would not be a good PR approach. It appears that Estrada’s improvement due to leronlimab wasn’t a big market mover, but his improvement has assisted in increasing the # of CSPs, it has increased leronlimab awareness in the PI and if that leads to an EUA, well, then that’s a victory.
Read More: https://investorshangout.com/post/view?id=611...z6tAIfbI1Z
CYDY will never release a PR making that claim because they cannot prove it definitively due to the other medications he was on. Yes, I agree, it’s likely his quick recovery and removal of the vent was due to leronlimab.
“PR is playing to the public, not to scientists.”
The PR is also playing to the SEC and the FDA. Stating that a drug still in trials is the reason for Estrada’s improvement would not be a good PR approach. It appears that Estrada’s improvement due to leronlimab wasn’t a big market mover, but his improvement has assisted in increasing the # of CSPs, it has increased leronlimab awareness in the PI and if that leads to an EUA, well, then that’s a victory.
Read More: https://investorshangout.com/post/view?id=611...z6tAIfbI1Z
(9)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼